Clinical utility of denosumab for treatment of bone loss in men and women
about
Pharmacologic interventions for preventing and treating periprosthetic osteoporosis following total hip arthroplastyDenosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsThe clinical approach toward giant cell tumor of boneIn Vitro Effects of Strontium on Proliferation and Osteoinduction of Human PreadipocytesManagement of bone metastases in refractory prostate cancer--role of denosumab.Pattern and cause of fractures in patients who abuse alcohol: what should we do about it?
P2860
Clinical utility of denosumab for treatment of bone loss in men and women
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical utility of denosumab for treatment of bone loss in men and women
@ast
Clinical utility of denosumab for treatment of bone loss in men and women
@en
type
label
Clinical utility of denosumab for treatment of bone loss in men and women
@ast
Clinical utility of denosumab for treatment of bone loss in men and women
@en
prefLabel
Clinical utility of denosumab for treatment of bone loss in men and women
@ast
Clinical utility of denosumab for treatment of bone loss in men and women
@en
P2860
P921
P356
P1476
Clinical utility of denosumab for treatment of bone loss in men and women
@en
P2093
Ranjodh S Gill
Robert A Adler
P2860
P304
P356
10.2147/CIA.S14565
P407
P577
2011-05-24T00:00:00Z